NASDAQ : LFST
LifeStance Health Group, Inc. — Key statistics
Healthcare · Medical Care Facilities · United States
Last price 13.4 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 5.12B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 5.12B |
| Enterprise Value | 5.37B |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 382.15M |
| Shares Outstanding | 382.15M |
| Shares Change (YoY) | +3.01% |
| Shares Change (QoQ) | -1.97% |
| Owned by Insiders (%) | 3.15% |
| Owned by Institutions (%) | 69.10% |
| Float | 290.31M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 104.00 |
| Forward PE | 72.43 |
| PS Ratio | 3.23 |
| Forward PS | 2.81 |
| PB Ratio | 3.47 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 29.45 |
| P/OCF Ratio | 23.50 |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 106.11 |
| EV / Sales | 3.39 |
| EV / EBITDA | 39.77 |
| EV / EBIT | 66.74 |
| EV / FCF | 30.87 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.38 |
| Quick Ratio | 1.23 |
| Debt / Equity | 0.32 |
| Debt / EBITDA | 2.45 |
| Debt / FCF | 2.73 |
| Interest Coverage | 7.95 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 3.43% |
| Return on Assets (ROA) | 2.32% |
| Return on Invested Capital (ROIC) | 3.49% |
| Return on Capital Employed (ROCE) | 4.22% |
| Weighted Average Cost of Capital (WACC) | 10.26% |
| Revenue Per Employee | $185,534 |
| Profits Per Employee | $5,924 |
| Employee Count | 8,542 |
| Asset Turnover | 0.73 |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | 16.39M |
| Effective Tax Rate | 24.47% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.24 |
| 52-Week Price Change | +169.08% |
| 50-Day Moving Average | 12.48 |
| 200-Day Moving Average | 9.34 |
| Relative Strength Index (RSI) | 64.82 |
| Average Volume (20 Days) | 2,972,107 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 13.77M |
| Short Previous Month | 15.51M |
| Short % of Shares Out | 3.60% |
| Short % of Float | 4.74% |
| Short Ratio (days to cover) | 2.99 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 1.58B |
| Gross Profit | 531.85M |
| Operating Income | 80.45M |
| Pretax Income | 66.99M |
| Net Income | 50.60M |
| EBITDA | 135.01M |
| EBIT | 80.45M |
| Earnings Per Share (EPS) | $0.13 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 225.94M |
| Total Debt | 474.15M |
| Net Cash | -248.21M |
| Net Cash Per Share | -$0.65 |
| Equity (Book Value) | 1.48B |
| Book Value Per Share | 3.87 |
| Working Capital | 103.21M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 217.87M |
| Capital Expenditures | -43.96M |
| Depreciation & Amortization | 54.56M |
| Net Borrowing | -10.88M |
| Free Cash Flow | 173.91M |
| FCF Per Share | $0.46 |
Margins
| Measure | Value |
|---|
| Gross Margin | 33.56% |
| Operating Margin | 5.08% |
| Pretax Margin | 4.23% |
| Profit Margin | 3.19% |
| EBITDA Margin | 8.52% |
| EBIT Margin | 5.08% |
| FCF Margin | 10.97% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -3.01% |
| Shareholder Yield | -3.01% |
| Earnings Yield | 0.96% |
| FCF Yield | 3.40% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $14.45 |
| Price Target Difference | 7.84% |
| Analyst Consensus | Buy |
| Analyst Count | 11 |
| Revenue Growth Forecast (3Y) | 16.52% |
| EPS Growth Forecast (3Y) | 40.27% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 2.53 |
| Piotroski F-Score | 7 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |